BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3523533)

  • 1. Reliability of videotape technology in assessing the efficacy of anti-emetic drugs.
    Triplett WC; Schroeder JE; Minnick DJ; Dugan WM; Berry JA
    Prog Clin Biol Res; 1986; 216():377-84. PubMed ID: 3523533
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
    Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
    Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum.
    Jacobs AJ; Deppe G; Cohen CJ
    Gynecol Oncol; 1980 Aug; 10(1):55-7. PubMed ID: 7190532
    [No Abstract]   [Full Text] [Related]  

  • 5. Chlorpromazine, placebo and droperidol in the treatment of nausea and vomiting associated with cisplatin therapy.
    Stuart-Harris R; Buckman R; Starke I; Wiltshaw E
    Postgrad Med J; 1983 Aug; 59(694):500-3. PubMed ID: 6353396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of droperidol in the prevention of cisplatin-induced delayed emesis: a double-blind, randomised parallel study.
    Minegishi Y; Ohmatsu H; Miyamoto T; Niho S; Goto K; Kubota K; Kakinuma R; Kudoh S; Nishiwaki Y
    Eur J Cancer; 2004 May; 40(8):1188-92. PubMed ID: 15110882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
    Cunningham D; Forrest GJ; Soukop M; Gilchrist NL; Calder IT; McArdle CS
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):864-5. PubMed ID: 2996690
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
    Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
    Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
    Johansson R; Kilkku P; Groenroos M
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():25-33. PubMed ID: 6299551
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind evaluation of the anti-emetic efficacy of benzquinamide, prochlorperazine and trimethobenzamide in office practice.
    Medoff J
    Curr Ther Res Clin Exp; 1970 Nov; 12(11):706-10. PubMed ID: 4993123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
    Padrón F; Sanz J; Flórez J
    Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents.
    Braude D; Soliz T; Crandall C; Hendey G; Andrews J; Weichenthal L
    Am J Emerg Med; 2006 Mar; 24(2):177-82. PubMed ID: 16490647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiemetic activity of droperidol administered by intramuscular injection during cisplatin chemotherapy: a pilot study.
    Cersosimo RJ; Bromer R; Hoffer S; Welch J; Abrahamson M; Hong WK
    Drug Intell Clin Pharm; 1985 Feb; 19(2):118-21. PubMed ID: 4038643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone in the treatment of nausea and vomiting from cancer chemotherapy.
    Winokur SH; Baker JJ; Lokey JL; Price NA; Bowen J
    J Med Assoc Ga; 1981 Apr; 70(4):263-4. PubMed ID: 7012258
    [No Abstract]   [Full Text] [Related]  

  • 15. Ineffectiveness of droperidol as antiemetic.
    Jackson M; Bozzino J; Prasad V; Warenius H
    Drug Intell Clin Pharm; 1985 Nov; 19(11):841-2. PubMed ID: 3905322
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents.
    Celik Y
    Am J Emerg Med; 2006 Sep; 24(5):643-4; author reply 644. PubMed ID: 16938620
    [No Abstract]   [Full Text] [Related]  

  • 17. The anti-emetic efficacy of a combination of ondansetron and droperidol.
    Chan MT; Gin T
    Anaesthesia; 1998 Apr; 53(4):413. PubMed ID: 9613323
    [No Abstract]   [Full Text] [Related]  

  • 18. [Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting?].
    Lehoczky O; Bagaméri A; Sárosi Z; Kulcsár T; Pulay T
    Orv Hetil; 2001 Aug; 142(31):1681-4. PubMed ID: 11556262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
    Kwong WJ; Parasuraman TV
    Pharm Pract Manag Q; 1999 Apr; 19(1):28-41. PubMed ID: 10351607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.